Top View
- GABAA Receptor Subtype- and Function-Selective Ligands: Key Issues in Translation to Humans
- PWZ-029, an Inverse Agonist Selective for Α5 GABAA Receptors, Improves
- Preclinical Pharmacology and Demonstration of Functional Target Engagement in Man Joerg F
- Selective Modulators of Α5-Containing GABAA Receptors and Their Therapeutic Significance
- 5-Selective Modulator, RO4938581, Rescues Protein Anomalies in the Ts65dn Mouse Model of Down Syndrome
- Ligand-Gated Ion Channels
- Tonic Gabaergic Activity Facilitates Dendritic Calcium Signaling and Short-Term Plasticity
- The Gabaergic Hypothesis for Cognitive Disabilities in Down Syndrome
- GABA Receptor Subtypes: Novel Targets for Novel Medicines
- WO 2017/065602 Al 20 April 2017 (20.04.2017) P O P C T
- Use of GABA Alpha5-Selective Inverse Agonists Carmen Martinez-Cué, B
- Full Abstracts SSN / CNB Joint Meeting 2014
- Disinhibition, an Emerging Pharmacology of Learning and Memory
- Print Version Is Our Products In-House, Thus Maintaining Control Over Our Manufacturing Process Available
- University of Dundee the CONCISE GUIDE TO
- Characterization of A3 GABAA Receptors Modified by RNA Editing
- Influence of Drugs on Cognitive Functions Influence of Drugs on Cognitive Functions
- WO 2016/114655 Al July 2016 (21.07.2016) W P O PCT
- Preclinical and Clinical Pharmacology of Basmisanil, a Novel Selective
- G Protein-Coupled Receptors
- Ligand-Gated Ion Channels
- ONO-8590580, a Novel GABAA Α5 Negative Allosteric Modulator Enhances Long-Term Potentiation and Improves Cognitive Deficits in Preclinical Models
- Benzodiazepine Receptor Ligands: a Patent Review (2006 -- 2012)
- Investigations of the Mechanism and Modulation of Gaba(A) Receptors and Their Potentiation by Dihydropyrimidinones
- Selective Inhibition of Extra-Synaptic Α5-GABAA Receptors by S44819, a New Therapeutic Agent